This study will evaluate whether talnetant (200mg, 400mg, 600mg) twice a day is effective compared to placebo and risperidone 1-3mg twice a day in treating the positive and negative symptoms of schizo
Introduction: Participant heterogeneity as a part of clinical heterogeneity has been proved to alter the intervention efficacy, however, factors associated with participant heterogeneity in psoriasis
*Kruskal-Wallis Test (comparing median between authors of reference),** Chi-square, Pearson.Characteristics of participants related to referral system.
